New Jersey A 1510: Improves access to lower-cost generic and biosimilar drugs.

Status: Introduced, Referred to Assembly Financial Institutions and Insurance Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: A 1510

Sponsors: Freiman, Roy

View New Jersey A 1510 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.